Artificial Beta Cell Particle Glucose-Sensing Insulin Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for diabetes, such as traditional intensive insulin therapy, imperfectly simulate the dynamics of β-cells and can cause hypoglycemia, while cell therapy is limited by the shortage of donor islets and requires immunosuppression.
Innovation Solution
A novel particle with a sense-and-response system, comprising an inner liposomal vesicle encapsulating a therapeutic agent, an outer liposomal vesicle encapsulating the inner vesicle, a membrane fusion-promoting agent, and a pH-altering agent, which mimics the function of pancreatic β-cells by sensing glucose levels and releasing insulin through membrane fusion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional intensive insulin therapy is used, then insulin delivery is achieved, but hypoglycemia occurs and β-cell dynamics are not properly simulated
Solution Approach 1:
The artificial β-cell incorporates a glucose-sensing mechanism that detects blood glucose levels and triggers insulin release only when glucose exceeds a threshold, creating a feedback loop that mimics natural β-cell behavior and prevents both hyper- and hypoglycemia
Solution Approach 2:
The system uses the body's own glucose levels as the trigger for insulin release, eliminating the need for external monitoring or control systems while achieving physiologically appropriate glycemic regulation
2Reliability
If cell therapy using donor islets is used, then β-cell function is restored, but immunosuppression is required and donor islets are scarce
Solution Approach 1:
Instead of using actual pancreatic islet cells, the invention creates a synthetic copy that replicates the glucose-sensing and insulin-release functions of β-cells using engineered particles, eliminating the need for donor tissue and immunosuppression
Solution Approach 2:
The system changes the fundamental approach from biological cell transplantation to synthetic particle-based therapy, transforming the parameters of donor availability and immune compatibility while maintaining the desired physiological function
3Ease of manufacture
If simple insulin injection is used, then insulin delivery is achieved, but dynamic response to glucose changes is lost
Solution Approach 1:
The artificial β-cell is designed with dynamic characteristics, where the insulin release rate automatically adjusts in response to changing glucose levels, replicating the pulsatile and proportional secretion pattern of natural β-cells
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The particle effectively distinguishes between high and normal glucose levels and responds by releasing insulin only in hyperglycemic conditions, thereby mimicking the functions of pancreatic β-cells and avoiding hypoglycemia.
Implementation Method 1
a pH-altering agent, wherein the pH-altering agent comprises a glucose-responsive enzyme
Implementation Method 2
a membrane fusion-promoting agent, wherein the membrane fusion-promoting agent promotes fusion between the inner liposomal vesicle and the outer liposomal vesicle
Data Source
AI summary
Disclosed herein is a particle containing an inner liposomal vesicle (ILV) encapsulating a therapeutic agent; an outer liposomal vesicle (OLV) encapsulating the ILV; a membrane fusion-promoting agent; and a pH-altering agent. Also disclosed are methods of delivering a therapeutic agent to a subject comprising: a) providing a herein disclosed particle b) triggering ILV and OLV fusion; and c) releasing the therapeutic agent outside of the OLV. Also disclosed are methods for treating a disease in a subject in need thereof comprising: administering to a subject a herein disclosed particle. Also disclosed are methods to release insulin to an environment comprising increased glucose levels, the method comprising exposing to the environment a herein disclosed particle.